Senores Pharma Reappoints Swapnil Shah as Managing Director, Chetan Shah as Whole-Time Director
Ahmedabad: Senores Pharmaceuticals Limited has approved the reappointment of Swapnil Jatinbhai Shah as Managing Director and Chetan Bipinchandra Shah as Whole-Time Director for a further term of three consecutive years.
The reappointment of Swapnil Jatinbhai Shah will be effective from October 15, 2026, while Chetan Bipinchandra Shah’s new term will begin on November 10, 2026. Both appointments are subject to shareholder approval through the postal ballot process.
Swapnil Jatinbhai Shah, the company’s promoter and Managing Director, has over 15 years of experience in the pharmaceutical sector. He oversees the company’s overall operations, product portfolio management, corporate strategy and business development.
Chetan Bipinchandra Shah, who also serves as Chief Operating Officer, brings over 30 years of professional experience, including 25 years in the pharmaceutical industry. He has previously been associated with Torrent Pharmaceuticals Limited and Cadila Pharmaceuticals Limited. His responsibilities include strategic planning, capacity expansion, manufacturing operations, supply chain management, risk management and mergers and acquisitions.
The reappointments are expected to maintain continuity in the company’s leadership and management, subject to the required shareholder approvals.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.